Literature DB >> 28300603

A Comprehensive Guide to the MAGE Family of Ubiquitin Ligases.

Anna K Lee1, Patrick Ryan Potts2.   

Abstract

Melanoma antigen (MAGE) genes are conserved in all eukaryotes and encode for proteins sharing a common MAGE homology domain. Although only a single MAGE gene exists in lower eukaryotes, the MAGE family rapidly expanded in eutherians and consists of more than 50 highly conserved genes in humans. A subset of MAGEs initially garnered interest as cancer biomarkers and immunotherapeutic targets due to their antigenic properties and unique expression pattern that is primary restricted to germ cells and aberrantly reactivated in various cancers. However, further investigation revealed that MAGEs not only drive tumorigenesis but also regulate pathways essential for diverse cellular and developmental processes. Therefore, MAGEs are implicated in a broad range of diseases including neurodevelopmental, renal, and lung disorders, and cancer. Recent biochemical and biophysical studies indicate that MAGEs assemble with E3 RING ubiquitin ligases to form MAGE-RING ligases (MRLs) and act as regulators of ubiquitination by modulating ligase activity, substrate specification, and subcellular localization. Here, we present a comprehensive guide to MAGEs highlighting the molecular mechanisms of MRLs and their physiological roles in germ cell and neural development, oncogenic functions in cancer, and potential as therapeutic targets in disease.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  E3 ligases; MAGE; cancer-testis antigens; ubiquitin

Mesh:

Substances:

Year:  2017        PMID: 28300603      PMCID: PMC5421567          DOI: 10.1016/j.jmb.2017.03.005

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  214 in total

1.  RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination.

Authors:  K L Lorick; J P Jensen; S Fang; A M Ong; S Hatakeyama; A M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 2.  RING domains: master builders of molecular scaffolds?

Authors:  K L Borden
Journal:  J Mol Biol       Date:  2000-02-04       Impact factor: 5.469

3.  Mage-b4, a novel melanoma antigen (MAGE) gene specifically expressed during germ cell differentiation.

Authors:  C Osterlund; V Töhönen; K O Forslund; K Nordqvist
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

4.  Disruption of the mouse necdin gene results in early post-natal lethality.

Authors:  M Gérard; L Hernandez; R Wevrick; C L Stewart
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

5.  Expression and imprinting of MAGEL2 suggest a role in Prader-willi syndrome and the homologous murine imprinting phenotype.

Authors:  S Lee; S Kozlov; L Hernandez; S J Chamberlain; C I Brannan; C L Stewart; R Wevrick
Journal:  Hum Mol Genet       Date:  2000-07-22       Impact factor: 6.150

6.  A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells.

Authors:  S Lucas; F Brasseur; T Boon
Journal:  Cancer Res       Date:  1999-08-15       Impact factor: 12.701

7.  Expression of MAGE-antigens in normal tissues and cancer.

Authors:  A A Jungbluth; K J Busam; D Kolb; K Iversen; K Coplan; Y T Chen; G C Spagnoli; L J Old
Journal:  Int J Cancer       Date:  2000-02-15       Impact factor: 7.396

8.  MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: four new members of the MAGE family with tumor-specific expression.

Authors:  S Lucas; E De Plaen; T Boon
Journal:  Int J Cancer       Date:  2000-07-01       Impact factor: 7.396

9.  Characterization of the DOC1/APC10 subunit of the yeast and the human anaphase-promoting complex.

Authors:  R Grossberger; C Gieffers; W Zachariae; A V Podtelejnikov; A Schleiffer; K Nasmyth; M Mann; J M Peters
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

10.  Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.

Authors:  B Thurner; I Haendle; C Röder; D Dieckmann; P Keikavoussi; H Jonuleit; A Bender; C Maczek; D Schreiner; P von den Driesch; E B Bröcker; R M Steinman; A Enk; E Kämpgen; G Schuler
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

View more
  42 in total

1.  Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.

Authors:  Sachet A Shukla; Pavan Bachireddy; Bastian Schilling; Christina Galonska; Qian Zhan; Clyde Bango; Rupert Langer; Patrick C Lee; Daniel Gusenleitner; Derin B Keskin; Mehrtash Babadi; Arman Mohammad; Andreas Gnirke; Kendell Clement; Zachary J Cartun; Eliezer M Van Allen; Diana Miao; Ying Huang; Alexandra Snyder; Taha Merghoub; Jedd D Wolchok; Levi A Garraway; Alexander Meissner; Jeffrey S Weber; Nir Hacohen; Donna Neuberg; Patrick R Potts; George F Murphy; Christine G Lian; Dirk Schadendorf; F Stephen Hodi; Catherine J Wu
Journal:  Cell       Date:  2018-04-12       Impact factor: 41.582

2.  Molecular evolution of type II MAGE genes from ancestral MAGED2 gene and their phylogenetic resolution of basal mammalian clades.

Authors:  Marcos De Donato; Sunday O Peters; Tanveer Hussain; Hectorina Rodulfo; Bolaji N Thomas; Masroor E Babar; Ikhide G Imumorin
Journal:  Mamm Genome       Date:  2017-05-17       Impact factor: 2.957

3.  Epigenetic activation of POTE genes in ovarian cancer.

Authors:  Ashok Sharma; Mustafa Albahrani; Wa Zhang; Christina N Kufel; Smitha R James; Kunle Odunsi; David Klinkebiel; Adam R Karpf
Journal:  Epigenetics       Date:  2019-03-04       Impact factor: 4.528

4.  Prevalence of Novel MAGED2 Mutations in Antenatal Bartter Syndrome.

Authors:  Anne Legrand; Cyrielle Treard; Isabelle Roncelin; Sophie Dreux; Aurélia Bertholet-Thomas; Françoise Broux; Daniele Bruno; Stéphane Decramer; Georges Deschenes; Djamal Djeddi; Vincent Guigonis; Nadine Jay; Tackwa Khalifeh; Brigitte Llanas; Denis Morin; Gilles Morin; François Nobili; Christine Pietrement; Amélie Ryckewaert; Rémi Salomon; Isabelle Vrillon; Anne Blanchard; Rosa Vargas-Poussou
Journal:  Clin J Am Soc Nephrol       Date:  2017-11-16       Impact factor: 8.237

5.  The Arg/N-degron pathway targets transcription factors and regulates specific genes.

Authors:  Tri T M Vu; Dylan C Mitchell; Steven P Gygi; Alexander Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

6.  Evolution of Melanoma Antigen-A11 (MAGEA11) During Primate Phylogeny.

Authors:  Christopher S Willett; Elizabeth M Wilson
Journal:  J Mol Evol       Date:  2018-03-24       Impact factor: 2.395

Review 7.  Emerging roles of the MAGE protein family in stress response pathways.

Authors:  Rebecca R Florke Gee; Helen Chen; Anna K Lee; Christina A Daly; Benjamin A Wilander; Klementina Fon Tacer; Patrick Ryan Potts
Journal:  J Biol Chem       Date:  2020-09-13       Impact factor: 5.157

8.  The Prader-Willi syndrome proteins MAGEL2 and necdin regulate leptin receptor cell surface abundance through ubiquitination pathways.

Authors:  Tishani Methsala Wijesuriya; Leentje De Ceuninck; Delphine Masschaele; Matthea R Sanderson; Karin Vanessa Carias; Jan Tavernier; Rachel Wevrick
Journal:  Hum Mol Genet       Date:  2017-11-01       Impact factor: 6.150

9.  Regulation of MAGE-A3/6 by the CRL4-DCAF12 ubiquitin ligase and nutrient availability.

Authors:  Ramya Ravichandran; Kiran Kodali; Junmin Peng; Patrick Ryan Potts
Journal:  EMBO Rep       Date:  2019-05-24       Impact factor: 8.807

10.  X-chromosome variants are associated with aldosterone producing adenomas.

Authors:  Oliver Gimm; Peter Söderkvist; Ravi Kumar Dutta; Malin Larsson; Thomas Arnesen; Anette Heie; Martin Walz; Piero Alesina
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.